- Home
- RVPH vs PMVP Comparison
RVPH vs PMVP Comparison
Compare RVPH & PMVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVPH
- PMVP
- Stock Information
- Founded
- RVPH 2006
- PMVP 2013
- Country
- RVPH United States
- PMVP United States
- Employees
- RVPH N/A
- PMVP N/A
- Industry
- RVPH Biotechnology: Pharmaceutical Preparations
- PMVP Medicinal Chemicals and Botanical Products
- Sector
- RVPH Health Care
- PMVP Health Care
- Exchange
- RVPH Nasdaq
- PMVP Nasdaq
- Market Cap
- RVPH 88.0M
- PMVP 71.9M
- IPO Year
- RVPH N/A
- PMVP 2020
- Fundamental
- Price
- RVPH $1.04
- PMVP $1.24
- Analyst Decision
- RVPH Strong Buy
- PMVP Strong Buy
- Analyst Count
- RVPH 5
- PMVP 3
- Target Price
- RVPH $11.40
- PMVP $5.33
- AVG Volume (30 Days)
- RVPH 1.1M
- PMVP 132.4K
- Earning Date
- RVPH 05-13-2025
- PMVP 03-03-2025
- Dividend Yield
- RVPH N/A
- PMVP N/A
- EPS Growth
- RVPH N/A
- PMVP N/A
- EPS
- RVPH N/A
- PMVP N/A
- Revenue
- RVPH N/A
- PMVP N/A
- Revenue This Year
- RVPH N/A
- PMVP N/A
- Revenue Next Year
- RVPH N/A
- PMVP N/A
- P/E Ratio
- RVPH N/A
- PMVP N/A
- Revenue Growth
- RVPH N/A
- PMVP N/A
- 52 Week Low
- RVPH $0.60
- PMVP $1.20
- 52 Week High
- RVPH $4.28
- PMVP $2.26
- Technical
- Relative Strength Index (RSI)
- RVPH 25.55
- PMVP 36.90
- Support Level
- RVPH $1.12
- PMVP $1.20
- Resistance Level
- RVPH $1.23
- PMVP $1.27
- Average True Range (ATR)
- RVPH 0.13
- PMVP 0.07
- MACD
- RVPH -0.03
- PMVP -0.01
- Stochastic Oscillator
- RVPH 0.00
- PMVP 16.00
About RVPH Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, and Parkinson's disease psychosis and its other drug candidate is RP1208.
About PMVP PMV Pharmaceuticals Inc.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which has the ability to eliminate cancer cells.